The New Metall-Beta-Lactamase’s Inhibitor Efficacy in a Model System in Vitro

Russian Journal of Infection and Immunity - Russian Federation
doi 10.15789/2220-7619-2016-4-335-344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SPb RAACI

Related search

Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model

PLoS ONE
Multidisciplinary
2013English

The 4-Aminopyridine Model of Acute Seizures in Vitro Elucidates Efficacy of New Antiepileptic Drugs

Frontiers in Neuroscience
Neuroscience
2019English

Alafosfalin, a New Inhibitor of Cell Wall Biosynthesis: In Vitro Activity Against Urinary Isolates in Japan and Potentiation With Beta-Lactams.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1979English

In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes Exposed to IL-1^|^beta;

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2012English

Cefclidin (E1040), a Novel Cephalosporin: Lack of Selection of .BETA.-lactamase Overproducing Mutants in an in Vitro Pharmacokinetic Model System.

Journal of Antibiotics
Drug DiscoveryPharmacology
1992English

The Comparative in Vitro Activity and .BETA.-lactamase Stability of a New Ureido Penicillin.

Journal of Antibiotics
Drug DiscoveryPharmacology
1979English

A New in Vitro Dormancy Model of Mycobacterium Tuberculosis

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2020English

In Vitro Activity of Ro 13-9904, a New Beta-Lactamase-Stable Cephalosporin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

In Vitro Activity and Beta-Lactamase Stability of a New Carbapenem, SM-7338.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy